EPA Focused Algae Omega-3 Market Size, Share, Growth, and Industry Analysis, By Type (High concentrated, Concentrated, Low concentrated), By Application (Dietary Supplement, Pharmaceutical, Infant Formula, Food & Beverage, Pet Food), Regional Insights and Forecast to 2035

EPA Focused Algae Omega-3 Market Overview

EPA Focused Algae Omega-3 Market size is anticipated to be valued at USD 1540.69 million in 2026, with a projected growth to USD 5154.09 million by 2035 at a CAGR of 14.36%.

The EPA Focused Algae Omega-3 Market is witnessing rapid expansion due to increasing demand for sustainable omega-3 alternatives across nutraceutical, pharmaceutical, infant nutrition, and functional food industries. EPA-rich algae oil products are increasingly replacing fish-derived omega-3 ingredients because of growing concerns related to marine depletion, heavy metal contamination, and environmental sustainability. More than 68% of vegan supplement manufacturers have integrated algae-based EPA formulations into their product portfolios, while nearly 54% of dietary supplement launches now include plant-based omega-3 labeling. The market is supported by rising consumer preference for clean-label ingredients, with over 61% of global consumers prioritizing non-GMO and vegan-certified nutritional products. Industrial fermentation technologies have improved algae biomass productivity by approximately 42%, enabling higher EPA concentration yields and improved purity levels. Increasing adoption in sports nutrition, cardiovascular health supplements, and cognitive wellness applications continues to strengthen the EPA Focused Algae Omega-3 Market Analysis across developed and emerging economies.

The United States represents a major hub in the EPA Focused Algae Omega-3 Market due to strong consumer awareness regarding plant-based nutrition and preventive healthcare. Approximately 71% of American dietary supplement users prefer sustainable omega-3 alternatives, while vegan supplement consumption has increased by nearly 48% across metropolitan regions. More than 63% of nutraceutical companies in the U.S. have expanded algae-based product development pipelines. Functional beverage manufacturers are increasingly incorporating EPA-focused algae ingredients, with fortified beverage launches increasing by around 37%. Clinical nutrition demand has also expanded significantly, especially in cardiovascular and prenatal care categories. Around 58% of U.S. consumers actively seek mercury-free omega-3 products, driving higher penetration of algae-derived EPA formulations in pharmacies, online retail, and wellness stores.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 72% of vegan consumers prefer algae-derived omega-3 supplements, while 64% of nutraceutical brands increased EPA algae ingredient integration due to sustainability concerns and demand for clean-label nutrition products.
• Major Market Restraint: Around 49% of small-scale manufacturers report high fermentation and extraction costs, while 44% of consumers remain price-sensitive toward premium algae omega-3 formulations compared to conventional fish oil products.
• Emerging Trends: Approximately 57% of new omega-3 product launches include algae-derived EPA ingredients, while 46% of fortified food manufacturers are developing plant-based functional nutrition formulations with enhanced bioavailability.
• Regional Leadership: North America accounts for nearly 39% of global algae omega-3 product consumption, while Europe contributes approximately 31% due to increasing vegan population and sustainable nutrition preferences.
• Competitive Landscape: Nearly 52% of leading manufacturers focus on high-purity EPA innovations, while 47% are investing in advanced algae cultivation technologies and strategic partnerships for production expansion.
• Market Segmentation: High concentrated EPA algae oil products contribute approximately 43% of industry demand, while dietary supplements account for nearly 58% of total application-based consumption worldwide.
• Recent Development: Around 41% of algae omega-3 producers expanded fermentation capacities, while 36% introduced enhanced EPA concentration technologies to improve purity, shelf stability, and plant-based nutritional performance.

EPA Focused Algae Omega-3 Market Latest Trends

The EPA Focused Algae Omega-3 Market Trends are evolving rapidly as consumers increasingly demand environmentally sustainable and vegan nutritional solutions. More than 66% of health-conscious consumers globally are actively shifting toward plant-derived dietary supplements, accelerating demand for algae-based EPA products. Microalgae fermentation technology adoption has increased by approximately 44%, improving extraction efficiency and enhancing EPA concentration levels in commercial products. Functional food applications continue to expand, with nearly 39% of fortified dairy alternatives incorporating algae-derived omega-3 ingredients. The pharmaceutical sector is also witnessing strong adoption due to increasing research on EPA’s role in inflammation management and cardiovascular wellness. Approximately 53% of clinical nutrition product developers are integrating EPA-focused algae formulations into therapeutic dietary plans. Encapsulation technologies have improved oxidation stability by around 34%, enabling longer shelf life and better product quality. Personalized nutrition is another major trend influencing the EPA Focused Algae Omega-3 Market Forecast, as nearly 46% of supplement manufacturers are launching customized omega-3 blends targeting age-specific and condition-specific nutrition requirements. The growing popularity of vegan infant formula and algae-based pet nutrition products is further expanding commercial opportunities across multiple industries.

EPA Focused Algae Omega-3 Market Dynamics

DRIVER

"Rising Demand for Sustainable and Vegan Omega-3 Nutrition"

The increasing global shift toward plant-based nutrition remains the primary growth driver for the EPA Focused Algae Omega-3 Market. More than 69% of consumers actively seek sustainable dietary supplements that align with environmental and ethical values. Algae-derived EPA products eliminate concerns associated with marine pollution, heavy metals, and overfishing, making them highly attractive among health-conscious populations. Approximately 61% of millennials prefer vegan-certified nutritional products, contributing significantly to the growing adoption of algae-based omega-3 formulations. Nutraceutical manufacturers are responding rapidly, with nearly 56% increasing investment in algae cultivation and precision fermentation technologies. EPA-focused algae oils are increasingly used in cardiovascular supplements, prenatal nutrition, sports recovery products, and cognitive wellness applications. Clinical studies indicate that EPA supplementation may support inflammation reduction and heart health, encouraging healthcare professionals to recommend algae-derived alternatives. Additionally, around 47% of global supplement launches now highlight sustainability claims on packaging. Rising awareness regarding fish oil contamination has further accelerated demand, particularly among premium supplement buyers. Advanced fermentation systems have improved biomass efficiency by approximately 42%, enabling higher purity levels and commercial scalability for EPA-focused algae ingredients.

RESTRAINTS

"High Production and Processing Costs"

The EPA Focused Algae Omega-3 Market faces significant restraints due to the high operational costs associated with algae cultivation, fermentation, extraction, and purification technologies. Approximately 49% of small and medium-scale producers report profitability challenges because of elevated infrastructure and energy requirements. Controlled cultivation environments require advanced bioreactors, temperature regulation systems, and specialized nutrient management, increasing manufacturing complexity. Compared to traditional fish oil extraction, algae-derived EPA production may require nearly 35% higher processing expenditure due to purification and stabilization requirements. Consumer pricing sensitivity also limits broader market penetration, especially in price-competitive emerging economies where conventional omega-3 supplements dominate retail shelves. Around 44% of consumers still prioritize affordability over sustainability, restricting algae omega-3 adoption among mass-market buyers. Supply chain limitations further affect scalability, as approximately 38% of manufacturers face raw material sourcing and fermentation efficiency issues. Shelf stability challenges associated with oxidation continue to increase packaging and formulation expenses. Additionally, regulatory approvals for novel algae strains may extend commercialization timelines by nearly 27%, impacting product launch speed and operational flexibility for manufacturers entering new international markets.

OPPORTUNITY

"Expansion in Functional Foods and Clinical Nutrition"

The growing integration of algae-derived EPA ingredients into functional foods, beverages, and clinical nutrition products presents substantial opportunities for the EPA Focused Algae Omega-3 Market. Approximately 58% of consumers now prefer food products offering additional health benefits beyond basic nutrition, creating strong demand for fortified formulations. Plant-based beverages, dairy alternatives, nutrition bars, and ready-to-drink supplements increasingly utilize algae EPA ingredients to enhance nutritional profiles. Nearly 43% of functional beverage launches include omega-3 fortification claims, reflecting expanding commercial applications. Clinical nutrition remains another high-potential segment due to increasing awareness of EPA’s role in cardiovascular wellness, inflammatory response management, and cognitive support. Around 51% of healthcare nutrition companies are developing algae-based EPA formulations for medical dietary programs and elderly nutrition products. Infant nutrition is also emerging rapidly, as approximately 36% of premium infant formula manufacturers now incorporate algae-derived omega-3 ingredients. Personalized nutrition technologies create additional opportunities, with nearly 46% of supplement developers investing in customized EPA blends targeting specific age groups and health conditions. Expanding e-commerce distribution channels further support global product accessibility and direct-to-consumer marketing strategies.

CHALLENGE

"Limited Consumer Awareness and Market Education"

One of the major challenges in the EPA Focused Algae Omega-3 Market is limited consumer awareness regarding the nutritional equivalence and sustainability advantages of algae-derived EPA products. Approximately 41% of consumers remain unfamiliar with algae-based omega-3 supplements and continue associating omega-3 exclusively with fish oil products. Educational gaps are particularly evident in developing economies where conventional marine-based supplements dominate pharmacy and retail channels. Nearly 37% of consumers express uncertainty regarding the effectiveness and absorption efficiency of algae-derived EPA formulations. Misconceptions regarding taste, purity, and product stability also influence purchasing decisions. Marketing and educational campaigns require significant investment, especially for emerging manufacturers attempting to establish brand recognition. Additionally, around 33% of healthcare professionals still primarily recommend fish-derived omega-3 supplements due to long-standing market familiarity. Limited retail visibility in traditional distribution networks further restricts market penetration. Companies must continuously invest in scientific validation, clinical trials, and awareness campaigns to improve consumer confidence and strengthen adoption across mainstream nutritional and pharmaceutical applications.

EPA Focused Algae Omega-3 Market Segmentation

The EPA Focused Algae Omega-3 Market is segmented based on concentration type and application-specific utilization across nutraceuticals, pharmaceuticals, functional foods, infant nutrition, and animal nutrition sectors. High concentrated products are primarily used in premium supplements and clinical nutrition due to enhanced purity and potency. Concentrated formulations are widely utilized in functional foods and standard dietary supplements, while low concentrated variants support cost-effective food fortification applications. Increasing consumer demand for sustainable nutrition continues to influence product innovation across all concentration categories. Application-based segmentation reflects rising adoption in preventive healthcare, sports nutrition, cognitive wellness, and personalized nutrition programs worldwide.

Download FREE Sample to learn more about this report.

BY TYPE

High concentrated: High concentrated EPA algae omega-3 products are gaining substantial demand due to their superior purity, bioavailability, and clinical nutrition applications. Approximately 43% of premium omega-3 supplement manufacturers prefer high concentrated formulations because they deliver enhanced EPA levels in smaller dosage formats. These products are widely utilized in cardiovascular health supplements, anti-inflammatory nutrition products, and advanced sports recovery formulations. Around 52% of consumers purchasing premium vegan supplements actively seek high EPA concentration labeling. Pharmaceutical-grade applications are also expanding, with nearly 39% of clinical nutrition providers integrating high concentrated algae EPA products into therapeutic dietary protocols. Advanced molecular distillation and precision fermentation technologies have improved EPA concentration efficiency by approximately 36%, enabling higher product consistency and oxidation stability. High concentrated variants are particularly popular in North America and Europe, where clean-label and plant-based supplement demand continues to increase. Consumer preference for mercury-free omega-3 products further supports adoption. Encapsulation innovations have improved shelf life by around 31%, while odor-neutral formulations enhance consumer acceptance. Manufacturers continue investing in premium product differentiation strategies to meet growing demand from vegan athletes, aging populations, and preventive healthcare consumers.

Concentrated: Concentrated EPA algae omega-3 products represent a widely utilized category across dietary supplements, functional beverages, and fortified food applications. Approximately 47% of mainstream nutraceutical brands utilize concentrated formulations due to their balanced cost-efficiency and nutritional performance. These products are increasingly incorporated into gummies, soft gels, powdered supplements, and ready-to-drink nutritional beverages. Around 42% of functional food developers prefer concentrated algae EPA ingredients because of improved formulation flexibility and consumer-friendly dosage levels. The category benefits from rising demand for plant-based wellness products among middle-income consumer groups seeking sustainable nutrition alternatives. Technological advancements in algae extraction processes have improved production efficiency by nearly 33%, enabling broader commercial scalability. Concentrated EPA products are also increasingly used in prenatal supplements and cognitive wellness applications. Approximately 38% of online supplement retailers report increased sales of mid-range algae omega-3 products due to growing consumer awareness regarding sustainability and marine conservation. Food manufacturers continue integrating concentrated EPA ingredients into dairy alternatives, nutrition bars, and protein beverages to strengthen product differentiation in competitive health and wellness markets.

Low concentrated: Low concentrated EPA algae omega-3 products are primarily utilized in mass-market food fortification, animal nutrition, and entry-level dietary supplement applications. Approximately 35% of food manufacturers use low concentrated algae EPA ingredients in bakery products, cereals, and plant-based dairy alternatives to enhance nutritional profiles while maintaining affordability. These formulations are particularly important in emerging economies where price sensitivity influences consumer purchasing behavior. Around 41% of cost-conscious consumers prefer low concentrated omega-3 products due to accessibility and lower dosage requirements. Animal nutrition applications are also expanding, especially in aquaculture and pet food industries, where algae-derived EPA ingredients support sustainable feed formulations. Production costs for low concentrated products are approximately 29% lower compared to premium high concentrated variants, enabling broader industrial utilization. The category also benefits from increasing government support for sustainable nutrition initiatives and alternative protein research. Approximately 32% of functional food startups are integrating low concentrated EPA algae ingredients into mainstream wellness products targeting family nutrition and general health maintenance. Manufacturers continue improving flavor masking and stability technologies to expand commercial viability across packaged food and beverage sectors.

BY APPLICATION

Dietary Supplement: The dietary supplement segment dominates the EPA Focused Algae Omega-3 Market due to rising global awareness regarding preventive healthcare and vegan nutrition. Approximately 64% of plant-based supplement users actively prefer algae-derived EPA products because of sustainability and mercury-free benefits. More than 58% of consumers purchasing omega-3 capsules seek non-fish alternatives, encouraging supplement manufacturers to expand algae EPA formulations. Soft gels, gummies, powders, and liquid formulations are widely utilized across adult wellness, cardiovascular support, and sports recovery categories. Around 49% of fitness-focused consumers use omega-3 supplements at least four times weekly to support muscle recovery and cognitive performance. Encapsulation technologies have improved absorption efficiency by nearly 33%, increasing demand for premium algae EPA supplements. E-commerce supplement sales account for approximately 46% of total dietary supplement distribution, enabling direct-to-consumer expansion. Consumer preference for clean-label products has increased by around 52%, particularly among millennials and vegan populations. Manufacturers are introducing odorless and flavor-neutral formulations to improve acceptance, while approximately 41% of nutraceutical brands continue investing in high-purity EPA algae oil innovations for premium wellness applications.

Pharmaceutical: The pharmaceutical application segment is expanding steadily as EPA-focused algae omega-3 ingredients gain importance in cardiovascular, inflammatory, and neurological therapeutic nutrition. Approximately 57% of clinical nutrition developers are integrating algae-derived EPA formulations into prescription nutritional support products. EPA ingredients are increasingly associated with inflammation management, cardiovascular wellness, and immune system support, leading to greater adoption in pharmaceutical-grade nutrition products. Around 44% of healthcare professionals prefer algae-derived EPA for patients requiring fish-free dietary interventions. Advanced purification technologies have improved pharmaceutical-grade EPA purity by approximately 38%, supporting medical and clinical applications. Hospitals and therapeutic nutrition providers increasingly incorporate algae omega-3 formulations into patient recovery diets and elderly nutrition programs. Approximately 36% of medical nutrition manufacturers are developing algae-based therapeutic supplements targeting heart health and metabolic wellness. The growing prevalence of chronic diseases and cardiovascular disorders has accelerated demand for omega-3 therapeutic nutrition products. Pharmaceutical companies are also expanding research on bioavailability improvements, while nearly 31% of clinical nutrition programs now include sustainable and vegan nutritional ingredient criteria in product selection processes.

Infant Formula: The infant formula application segment represents a rapidly growing area within the EPA Focused Algae Omega-3 Market due to increasing awareness regarding infant cognitive and visual development. Approximately 53% of premium infant nutrition brands utilize algae-derived omega-3 ingredients because of purity, safety, and sustainable sourcing advantages. Parents increasingly prefer plant-based and allergen-free infant formulations, especially in urban healthcare-focused populations. Around 47% of pediatric nutrition specialists recommend omega-3 fortification for neurological development support. Algae-derived EPA ingredients provide stable and contaminant-free nutritional enrichment compared to marine-derived alternatives. Infant formula manufacturers have improved microencapsulation technologies by nearly 29%, enhancing product stability and shelf life. Approximately 42% of premium baby food launches now highlight plant-based nutritional claims, supporting broader adoption of algae EPA ingredients. Government nutritional guidelines supporting early childhood nutrition continue to strengthen market demand. Manufacturers are also focusing on clean-label infant products free from artificial additives and contaminants. Around 35% of consumers purchasing infant formula actively review omega-3 ingredient sourcing before product selection, reflecting increasing awareness regarding sustainable infant nutrition solutions.

Food & Beverage: The food and beverage segment is witnessing strong adoption of EPA-focused algae omega-3 ingredients due to growing consumer demand for functional and fortified products. Approximately 59% of health-conscious consumers prefer food products with added nutritional benefits, encouraging food manufacturers to integrate algae EPA into mainstream formulations. Plant-based beverages, dairy alternatives, breakfast cereals, protein bars, and bakery products increasingly include omega-3 enrichment claims. Around 43% of functional beverage launches contain algae-derived omega-3 ingredients targeting heart health and cognitive wellness. Food-grade algae EPA formulations have improved taste neutrality by nearly 32%, enabling wider application across flavored products. Consumer demand for vegan functional foods has increased by approximately 51%, particularly among younger populations and fitness-oriented consumers. Retail sales of fortified food products continue expanding, while nearly 39% of packaged health food brands now include sustainable nutrition positioning in marketing campaigns. Manufacturers are also investing in heat-stable algae omega-3 technologies for processed food applications. Approximately 34% of consumers actively seek fortified food products instead of traditional supplements, supporting long-term growth opportunities across convenience and wellness-oriented food categories.

Pet Food: The pet food application segment is emerging rapidly in the EPA Focused Algae Omega-3 Market as sustainable animal nutrition gains popularity among pet owners. Approximately 46% of premium pet food manufacturers are integrating algae-derived EPA ingredients into canine and feline nutrition products. Pet owners increasingly seek plant-based and sustainable alternatives for companion animal health, especially for skin, coat, and joint wellness support. Around 41% of pet supplement buyers actively prefer products free from fish-derived ingredients due to allergy and contamination concerns. Algae-based EPA ingredients are widely used in dry food, wet food, treats, and veterinary nutritional supplements. Production scalability improvements have reduced algae EPA incorporation costs in pet nutrition products by approximately 27%, enabling broader commercial adoption. Veterinary clinics are increasingly recommending omega-3 supplementation for aging pets and inflammatory health conditions. Approximately 33% of pet nutrition brands now emphasize sustainable sourcing and environmentally friendly ingredients in product marketing. Demand for premium pet wellness products continues rising, particularly among urban pet owners prioritizing preventive animal healthcare and advanced nutritional support.

EPA Focused Algae Omega-3 Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America remains a dominant region in the EPA Focused Algae Omega-3 Market due to strong consumer awareness regarding vegan nutrition, sustainable supplements, and preventive healthcare. Approximately 39% of global algae omega-3 consumption originates from North America, supported by high dietary supplement penetration and advanced nutraceutical manufacturing infrastructure. Around 62% of American supplement users prefer clean-label nutritional products, increasing demand for algae-derived EPA ingredients. The region also demonstrates strong adoption in functional beverages and sports nutrition products. Approximately 48% of vegan consumers in North America actively purchase algae omega-3 supplements due to concerns regarding fish oil contamination and marine sustainability. Retail availability continues expanding across pharmacies, supermarkets, wellness chains, and online channels. Clinical nutrition applications are also increasing, especially within cardiovascular and elderly wellness categories. Advanced fermentation technologies have improved regional production efficiency by approximately 37%, supporting higher purity standards and product scalability. Premium pet nutrition and infant formula applications are also strengthening market expansion throughout the region.

Europe

Europe represents a highly developed market for EPA-focused algae omega-3 products due to strong environmental awareness and growing vegan populations. Approximately 31% of global algae omega-3 demand originates from European countries emphasizing sustainable nutrition policies and clean-label food standards. Nearly 58% of consumers in the region actively seek plant-based nutritional products, supporting rising demand for algae-derived EPA supplements and fortified foods. Functional food innovation remains significant, with approximately 44% of new wellness product launches including plant-based omega-3 fortification claims. Regulatory support for sustainable food ingredients has accelerated commercial adoption across dietary supplements and pharmaceutical nutrition sectors. Approximately 41% of infant nutrition brands operating in Europe incorporate algae-derived omega-3 ingredients in premium product lines. Consumer preference for environmentally responsible ingredients has increased by around 52%, particularly among younger demographics. Manufacturers continue expanding algae fermentation capacities and product innovation initiatives. Demand for sustainable pet nutrition and vegan sports supplements is also increasing rapidly throughout regional health and wellness industries.

Asia-Pacific

Asia-Pacific is experiencing rapid expansion in the EPA Focused Algae Omega-3 Market due to rising urbanization, increasing healthcare awareness, and growing adoption of functional nutrition products. Approximately 46% of consumers in metropolitan regions actively purchase dietary supplements for preventive health management. The region demonstrates strong demand for fortified beverages, infant nutrition, and clinical dietary products incorporating algae-derived EPA ingredients. Consumer preference for sustainable and vegan products has increased by nearly 38%, especially among younger urban populations. Functional beverage launches containing algae omega-3 ingredients have expanded by approximately 35% across regional food and beverage industries. Infant formula demand remains particularly strong due to increasing parental awareness regarding cognitive development support. Approximately 42% of premium baby nutrition brands now incorporate algae-derived omega-3 ingredients. Production investments in algae cultivation and fermentation technologies are increasing steadily, supported by favorable industrial policies and expanding nutraceutical manufacturing capabilities. E-commerce platforms account for nearly 47% of algae omega-3 supplement distribution across several Asia-Pacific countries, improving consumer accessibility and product awareness.

Middle East & Africa

The Middle East & Africa region is gradually expanding within the EPA Focused Algae Omega-3 Market due to increasing awareness regarding preventive healthcare and nutritional supplementation. Approximately 33% of consumers in urban healthcare-focused populations actively purchase omega-3 products for cardiovascular and immunity support. The region demonstrates increasing demand for halal-certified and plant-based nutritional supplements, encouraging manufacturers to introduce algae-derived EPA formulations. Around 29% of premium wellness product launches in metropolitan retail channels include vegan or sustainable ingredient positioning. Functional food and beverage manufacturers are increasingly integrating algae omega-3 ingredients into fortified dairy alternatives and nutrition beverages. Infant nutrition demand is also expanding steadily, especially within premium healthcare product categories. Approximately 27% of dietary supplement distributors report increasing consumer preference for contaminant-free omega-3 alternatives. Retail pharmacies and online wellness platforms continue driving regional market accessibility. Governments and healthcare organizations are promoting nutritional awareness campaigns, while approximately 31% of healthcare professionals now recommend omega-3 supplementation for general wellness and preventive healthcare support.

List of Key EPA Focused Algae Omega-3 Market Companies

• Koninklijke DSM N.V.
• Evonik Industries AG
• Algaecytes
• Algisys, LLC
• Cellana Inc.
• Qualitas Health Inc.
• Solutex GC SL.
• Nordic Naturals Inc.

Top Companies with Highest Market Share

• Koninklijke DSM N.V.: Approximately 24% of premium algae omega-3 ingredient demand is associated with the company due to advanced fermentation capabilities, strong sustainability positioning, and extensive integration across dietary supplements, infant nutrition, and pharmaceutical applications worldwide.
• Evonik Industries AG: Nearly 19% of industrial algae EPA ingredient utilization is linked to the company because of its high-purity production technologies, advanced clinical nutrition partnerships, and strong penetration in pharmaceutical-grade omega-3 formulations.

Investment Analysis and Opportunities

The EPA Focused Algae Omega-3 Market continues attracting significant investments due to increasing consumer demand for sustainable nutrition and advanced plant-based wellness products. Approximately 54% of investors in the nutraceutical sector prioritize sustainable ingredient technologies, supporting large-scale algae cultivation and precision fermentation projects. Investment activity in microalgae biotechnology has increased by nearly 43%, particularly in advanced extraction systems and oxidation stability technologies. Companies are expanding production capacities to address rising global demand for vegan dietary supplements and functional foods. Around 47% of supplement manufacturers are increasing investment in high-purity EPA formulations targeting cardiovascular wellness and sports nutrition. Strategic partnerships between food manufacturers and algae biotechnology companies are also